Founder/CEO
100XBIO
The company specializes in T-cell antigen specificity and sequencing analysis through proprietary technology that enhances the understanding of T-cell receptor diversity. This capability is crucial for advancing immunology research, immunotherapy development, and improving disease diagnosis and treatment outcomes.
- Biotechnology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The company specializes in T-cell antigen specificity and sequencing analysis through proprietary technology that enhances the understanding of T-cell receptor diversity. This capability is crucial for advancing immunology research, immunotherapy development, and improving disease diagnosis and treatment outcomes.